-
Crown Laboratories and Revance Amend the A&R Merger Agreement to Increase Offer Price to $3.65 per Share and Extend Existing Tender Offer
21 Jan 2025 13:11 GMT
… previously announced Amended and Restated Merger Agreement (the “Second Amendment … entered into the original merger agreement on August 11, … that Crown and its acquisition subsidiary filed with the … Revance
Revance is a biotechnology company setting the new …
-
Kane to Host Investor Webinar – What Kane has in Store for 2025 Including the Acquisition of FB Dermatology
21 Jan 2025 13:30 GMT
WINNIPEG, Manitoba, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday, January 23, 2025 at 4:15pm Eastern Time. Participants can register for the webinar by using …
-
VaxCell-Bio to merge with ALBIOTEK, expanding cancer immunotherapy pipeline
21 Jan 2025 05:11 GMT
VaxCell-Bio, a Korean biotech company specializing in immunotherapies … acquire and merge with ALBIOTEK (ALB), a Korean biotech company … VaxCell-Bio official, the merger will be finalized on … -Bio completed the absorption merger of seahanpharm, a pharmaceutical …
-
Is biotech M&A set to surge in 2025?
20 Jan 2025 19:30 GMT
… quot; indicates required fields
Mergers and acquisitions (M&As) … any other industry, the biotech sector depends on a … “There were no public biotech takeouts for more than … Smaller biotech firms with innovative solutions may become attractive acquisition …
-
Terrapinn on the lookout for scalable show acquisitions
20 Jan 2025 18:31 GMT
Terrapinn is back on the acquisition trail, according to the organiser’ … in the chemical, energy, medical, biotech, food and environment industries.
In …
-
Sun Pharma unit poised to buy Canadian biotech Antibe
19 Jan 2025 19:50 GMT
… over by Taro Pharmaceutical – which merged with Sun Pharma unit last … was a dispute with Shanghai biotech Nuance Pharma over a licensing …
-
A Huge Biotech Purchase Highlights New Year’s Insider Buying
19 Jan 2025 15:42 GMT
… petroleum refiner, and another biotech company also had a beneficial … .
Immunovant
New York-based biotech sees huge insider buying.
… York-based special purpose acquisition company founded in November … BC
Big expectations for this biotech.
Buyer(s): 10% owner …
-
Oragenics, Inc. Provides Shareholder Update on Strategic Progress and Announces Janet Huffman as Interim CEO
21 Jan 2025 13:15 GMT
… Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for … experience in capital raising, mergers and acquisitions, and financial planning. Before … Oragenics is a development-stage biotechnology company focused on nasal delivery …
-
Peripheral Nerve Injuries Market Set for Significant Growth by 2034, Report by DelveInsight
21 Jan 2025 11:50 GMT
… . It also analyzes recent collaborations, acquisitions, mergers, licensing patent details, and other … ;TRx0237: TauRx Therapeutics
• ABvac40: Araclon Biotech S.L.
• ACI-35.030 …
-
Malignant Ascites Market Poised for Robust Growth by 2034, Says DelveInsight
21 Jan 2025 11:49 GMT
… Biopharmaceuticals, Binhui Biopharmaceutical, Pharmacyte Biotech Inc., and others.
• … also analyzes recent collaborations, acquisitions, mergers, licensing patent details, and … CYPSCAPS PLUS IFOSFAMIDE: PHARMACYTE BIOTECH INC.
Malignant Ascites Market …
About
© 1995-2025